ng-nitroarginine methyl ester has been researched along with Angioma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, Y; Guo, ZT; Huang, Q; Li, P; Pan, WK | 1 |
1 other study(ies) available for ng-nitroarginine methyl ester and Angioma
Article | Year |
---|---|
Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
Topics: Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Cell Cycle Checkpoints; Cell Proliferation; Cells, Cultured; Chromones; Cinnamates; Cyclin A2; Cyclin D2; Cyclin-Dependent Kinase Inhibitor p21; Endothelial Cells; Hemangioma; Humans; Infant; Infant, Newborn; Morpholines; Neoplasm Invasiveness; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Norepinephrine; Pericytes; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proliferating Cell Nuclear Antigen; Propranolol; Proto-Oncogene Proteins c-akt; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2015 |